🔎 Trials Near Me

Akèy › Fèbli Kognitif Lejè › Massachusetts › Boston

Etid klinik pou Fèbli Kognitif Lejè nan Boston, MA

21 etid pou Fèbli Kognitif Lejè ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

Ap rekriteFaz 2
  • Massachusetts General Hospital - Charlestown, Charlestown · 1 mi lwen
Laj 55 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589595

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Ap rekriteFaz 3
  • Adams Clinical Boston, Boston
Laj 50 a 90 · Tout sèks · Mizajou Sep 21, 2026 · NCT07177352

Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY

Ap rekriteEtid obsèvasyon
  • Massachusetts General Hospital, Boston
  • Boston Medical Center, Boston
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT04916210

Sleep and Circadian Rhythm Biomarkers of Postoperative Delirium

Ap rekriteEtid obsèvasyon
  • Massachusetts General Hospital, Boston
Laj 70 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT06052397

Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
Laj 30 a 90 · Tout sèks · Mizajou Sep 1, 2026 · NCT04124029

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

Ap rekriteFaz 4Volontè an sante akeyi
  • VA Boston Healthcare System, Boston
Laj 75 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT04262206

A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

Ap rekriteFaz 1
  • Massachusetts General Hospital (MGH), Charlestown · 1 mi lwen
Laj 50 a 85 · Tout sèks · Mizajou Aug 24, 2026 · NCT06297590

Use of a Mobile Brain-Body Imaging Approach to Evaluate the Effects of Rhythmic Auditory Stimulation on Gait and Brain Function in Alzheimer's Disease

Ap rekriteVolontè an sante akeyi
  • Boston University Neuromotor Recovery Laboratory, Boston
Laj 50 a 90 · Tout sèks · Mizajou Aug 13, 2026 · NCT07659964

Individual Closed-Loop Neuromodulation Therapy for Alzheimer's Disease

Ap rekriteVolontè an sante akeyi
  • Massachusetts General Hospital, Charlestown · 1 mi lwen
Laj 50 a 80 · Tout sèks · Mizajou Jul 14, 2026 · NCT05904132

Healthy Aging as Black Adults, In It Together: a Comparative Effectiveness Study of Chronic Pain and Cognitive Decline

Ap rekrite
  • Massachusetts General Hospital, Boston
Laj 50 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT06246929

Biomarker-based Trial of NPC-1 for Alzheimer's Pathology

Ap rekriteFaz 2
  • Massachusetts General Hospital, Boston
Laj 55 ak plis · Tout sèks · Mizajou Jun 8, 2026 · NCT07236190

Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease

Ap rekriteFaz 1 bonèVolontè an sante akeyi
  • Massachusetts General Hospital, Boston
Laj 40 a 99 · Tout sèks · Mizajou May 6, 2026 · NCT06538311

Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Massachusetts General Hospital, Boston
Laj 18 a 100 · Tout sèks · Mizajou Mar 6, 2026 · NCT05881239

TMS for Cognitive Decline in Aging and Preclinical AD

Ap rekriteVolontè an sante akeyi
  • Massachusetts General Hospital, Boston
Laj 40 a 99 · Tout sèks · Mizajou Feb 20, 2026 · NCT06956300

Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease

Ap rekriteFaz 2
  • Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Boston
Laj 60 a 85 · Tout sèks · Mizajou Feb 12, 2026 · NCT06489548

Treating Insomnia in Mild Cognitive Impairment

Ap rekrite
  • Beth Israel Deaconess Medical Center, Boston
Laj 60 ak plis · Tout sèks · Mizajou Oct 24, 2025 · NCT06687161

LIFT: Life Improvement Trial

Ap rekriteFaz 2
  • Brigham and Women's Hospital, Boston
Laj 18 a 70 · Tout sèks · Mizajou Oct 22, 2025 · NCT06366724

Leveraging Social Networks to Improve Sleep and Mindfulness Among Older Adults in Residential Housing Facilities

Ap rekriteVolontè an sante akeyi
  • Brigham and Women's Hospital, Boston
Laj 55 ak plis · Tout sèks · Mizajou May 25, 2025 · NCT06989619

Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab

Ap rekriteFaz 2
  • Massachusetts General Hospital, Boston
Laj 25 a 50 · Tout sèks · Mizajou May 7, 2025 · NCT06136546

Cognitive Dysfunction in Chronic and Persistent Immune Thrombocytopenia

Ap rekriteEtid obsèvasyon
  • Massachusetts General Hospital, Boston
Laj 18 ak plis · Tout sèks · Mizajou Feb 10, 2025 · NCT06817395

Mindfulness for Cognition in Early-stage Alzheimer's Disease

Ap rekriteVolontè an sante akeyi
  • VA Boston Healthcare System - Jamaica Plain Campus, Boston
Laj 50 a 100 · Tout sèks · Mizajou Jan 27, 2025 · NCT06792877

Etid Fèbli Kognitif Lejè nan lòt vil

Lòt etid nan Boston

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.